+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Gabapentin Global Market Report 2025 - Product Thumbnail Image

Gabapentin Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Neuropathic Pain Market Report 2025 - Product Thumbnail Image

Neuropathic Pain Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Chronic Pain Market Report 2025 - Product Thumbnail Image

Chronic Pain Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Post Operative Pain Management Global Market Report 2025 - Product Thumbnail Image

Post Operative Pain Management Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Oxycodone Hydrochloride - Global Strategic Business Report - Product Thumbnail Image

Oxycodone Hydrochloride - Global Strategic Business Report

  • Report
  • November 2025
  • 361 Pages
  • Global
From
Pregabalin - Global Strategic Business Report - Product Thumbnail Image

Pregabalin - Global Strategic Business Report

  • Report
  • November 2025
  • 372 Pages
  • Global
From
Cancer Pain Management - Global Strategic Business Report - Product Thumbnail Image

Cancer Pain Management - Global Strategic Business Report

  • Report
  • November 2025
  • 588 Pages
  • Global
From
From
Gabapentin - Global Strategic Business Report - Product Thumbnail Image

Gabapentin - Global Strategic Business Report

  • Report
  • November 2025
  • 477 Pages
  • Global
From
Pain Management Drugs - Global Strategic Business Report - Product Thumbnail Image

Pain Management Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 250 Pages
  • Global
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • November 2025
  • 482 Pages
  • Global
From
Pain Management Devices Market - Global Forecast 2025-2032 - Product Thumbnail Image

Pain Management Devices Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
Pain Management Devices - Global Strategic Business Report - Product Thumbnail Image

Pain Management Devices - Global Strategic Business Report

  • Report
  • November 2025
  • 118 Pages
  • Global
From
From
Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
From
Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Neuropathic Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Neuropathic Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Pain- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Ocular Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 65 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more